Hegenberger Medical is pleased to announce that Benetec BV has been appointed as a strategic Enterprise Partner and the exclusive distribution partner of the Hegenberger Retractor in the territories of Belgium and Luxembourg.

The Hegenberger retractor, invented by Danish midwife Malene Hegenberger, is a unique, innovative and award-winning device, which transforms postpartum exploration and suturing by providing a clear view of the vaginal walls and perineum, improving outcomes for women with postpartum tears. The Hegenberger Retractor is the first innovation in this field of obstetric practice for over 150 years.

Benetec BV is a leading company in the distribution of medical, medical equipment, instruments, and consumables to the Benelux healthcare facilities. Benetec provides a vast clinical experience and a deep knowledge of the local market thanks to 35 years providing innovative and quality healthcare solutions, offering continuous education through our range of workshops, webinars and other courses.

Rob Maas, Managing Director said, “We are pleased to partner up with Hegenberger Medical. The Hegenberger retractor is simply better than another set of hands during suturing. We are convinced that this innovative product will help many clinicians to improve efficiency and most of all the outcome for their patients.

Hegenberger Medical is delighted for the support provided by the Department of International Trade (DIT) in Belgium by providing a better understanding of the market entry strategy. Mathieu Vanoverberghe, Head of Trade at British Embassy in Brussels said, “DIT Brussels, the Trade Promotion Agency of the UK Government in Belgium, is honoured and proud to have been able to support Hegenberger’s entry into the BeLux market. Benetec BV is a strong name within the sector in Belgium, and we are delighted that this partnership has been established. We are confident this product will improve obstetric practices for medical practitioners in general and improve patients’ quality of life in particular, as clearly demonstrated in other European markets”.